NEW YORK (GenomeWeb) – Natera is aiming to raise $75 million in a follow-on public offering of shares of its common stock, the firm reported after the close of the market on Tuesday. It also expects to grant underwriters a 30-day option to purchase up to an additional $11.25 million worth of common stock.

JP Morgan, Morgan Stanley, and Cowen are acting as joint book-running managers for the offering, which will be made only through a prospectus and related prospectus supplement, copies of which can be obtained from JP Morgan Securities.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.